vs
Side-by-side financial comparison of Black Stone Minerals, L.P. (BSM) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $95.2M, roughly 1.7× Black Stone Minerals, L.P.). Black Stone Minerals, L.P. runs the higher net margin — 75.9% vs 71.2%, a 4.7% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -8.7%).
Black Stone Minerals, L.P., or Black Stone Minerals, is a Houston, Texas-based oil and natural gas corporation.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
BSM vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $95.2M | $158.6M |
| Net Profit | $72.2M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 78.6% | 70.2% |
| Net Margin | 75.9% | 71.2% |
| Revenue YoY | -8.7% | 3661.1% |
| Net Profit YoY | 55.8% | 528.0% |
| EPS (diluted) | — | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $95.2M | — | ||
| Q3 25 | $105.2M | — | ||
| Q2 25 | $106.7M | — | ||
| Q1 25 | $115.3M | $158.6M | ||
| Q4 24 | $104.3M | $22.6M | ||
| Q3 24 | $103.2M | — | ||
| Q2 24 | $115.2M | — | ||
| Q1 24 | $116.8M | — |
| Q4 25 | $72.2M | — | ||
| Q3 25 | $91.7M | — | ||
| Q2 25 | $120.0M | — | ||
| Q1 25 | $15.9M | $112.9M | ||
| Q4 24 | $46.3M | $-10.5M | ||
| Q3 24 | $92.7M | — | ||
| Q2 24 | $68.3M | — | ||
| Q1 24 | $63.9M | — |
| Q4 25 | 78.6% | — | ||
| Q3 25 | 89.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 14.9% | 70.2% | ||
| Q4 24 | 45.6% | -60.4% | ||
| Q3 24 | 90.2% | — | ||
| Q2 24 | 59.5% | — | ||
| Q1 24 | 54.8% | — |
| Q4 25 | 75.9% | — | ||
| Q3 25 | 87.2% | — | ||
| Q2 25 | 112.5% | — | ||
| Q1 25 | 13.8% | 71.2% | ||
| Q4 24 | 44.4% | -46.4% | ||
| Q3 24 | 89.9% | — | ||
| Q2 24 | 59.3% | — | ||
| Q1 24 | 54.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.90 | ||
| Q4 24 | — | $-0.15 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $350.1M |
| Total Assets | $1.3B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | — | ||
| Q3 25 | $2.9M | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $2.4M | $274.8M | ||
| Q4 24 | $2.5M | $128.0M | ||
| Q3 24 | $21.0M | — | ||
| Q2 24 | $26.7M | — | ||
| Q1 24 | $40.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $350.1M | ||
| Q4 24 | — | $229.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.2B | $406.9M | ||
| Q4 24 | $1.2B | $271.6M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $65.1M | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 0.90× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.1M | — | ||
| Q3 25 | $99.8M | — | ||
| Q2 25 | $80.5M | — | ||
| Q1 25 | $64.8M | $131.8M | ||
| Q4 24 | $91.0M | $-23.2M | ||
| Q3 24 | $93.2M | — | ||
| Q2 24 | $100.4M | — | ||
| Q1 24 | $104.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $131.7M | ||
| Q4 24 | — | $-23.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 83.0% | ||
| Q4 24 | — | -102.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.90× | — | ||
| Q3 25 | 1.09× | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 4.07× | 1.17× | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.47× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BSM
| Oil Reserves | $46.4M | 49% |
| Natural Gas Reserves | $44.1M | 46% |
| Real Estate | $4.7M | 5% |
STOK
Segment breakdown not available.
